NuVasive (NASDAQ:NUVA) Research Coverage Started at StockNews.com

StockNews.com initiated coverage on shares of NuVasive (NASDAQ:NUVA – Free Report) in a research note released on Friday morning. The brokerage issued a hold rating on the medical device company’s stock. Other equities analysts also recently issued research reports about the stock. Barclays boosted their target price on shares of NuVasive from $56.00 to $58.00 […]

Related Keywords

,Quadrant Capital Group ,Nuvasive Company Profile ,Covestor Ltd ,Morgan Stanley ,Barclays ,Nuvasive Inc ,Nasdaq ,Investment Advisers ,Beaird Harris Wealth Management ,Nisa Investment Advisors ,Free Report ,Get Free Report ,Capital Group ,Harris Wealth Management ,Investment Advisors ,Nuvasive Daily ,Nuvasive ,Nasdaq Nuva ,Tnuva ,Medical ,67070410 ,Initiated Coverage ,Stocknews Com ,